Search

Waymond D. Bray

Examiner (ID: 831)

Most Active Art Unit
3201
Art Unit(s)
3725, 2899, 3204, 3201, 3203
Total Applications
3197
Issued Applications
3049
Pending Applications
43
Abandoned Applications
104

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7281277 [patent_doc_number] => 20040063654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Methods and compositions for therapeutic use of RNA interference' [patent_app_type] => new [patent_app_number] => 10/440506 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24879 [patent_no_of_claims] => 231 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063654.pdf [firstpage_image] =>[orig_patent_app_number] => 10440506 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/440506
Methods and compositions for therapeutic use of RNA interference May 14, 2003 Abandoned
Array ( [id] => 6830354 [patent_doc_number] => 20030181412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Method for modifying transcription and/or translation in an organism for therapeutic, prophylactic and/or analytic uses' [patent_app_type] => new [patent_app_number] => 10/438151 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 22409 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181412.pdf [firstpage_image] =>[orig_patent_app_number] => 10438151 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/438151
Method for modifying transcription and/or translation in an organism for therapeutic, prophylactic and/or analytic uses May 13, 2003 Abandoned
Array ( [id] => 7673341 [patent_doc_number] => 20040180438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Methods and compositions for silencing genes without inducing toxicity' [patent_app_type] => new [patent_app_number] => 10/425006 [patent_app_country] => US [patent_app_date] => 2003-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 34069 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180438.pdf [firstpage_image] =>[orig_patent_app_number] => 10425006 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/425006
Methods and compositions for silencing genes without inducing toxicity Apr 27, 2003 Abandoned
Array ( [id] => 7444237 [patent_doc_number] => 20040009510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Allosteric nucleic acid sensor molecules' [patent_app_type] => new [patent_app_number] => 10/422050 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 47542 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009510.pdf [firstpage_image] =>[orig_patent_app_number] => 10422050 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/422050
Allosteric nucleic acid sensor molecules Apr 22, 2003 Abandoned
Array ( [id] => 7367395 [patent_doc_number] => 20040006036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Silencing transcription by methylation' [patent_app_type] => new [patent_app_number] => 10/422466 [patent_app_country] => US [patent_app_date] => 2003-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15884 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006036.pdf [firstpage_image] =>[orig_patent_app_number] => 10422466 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/422466
Silencing transcription by methylation Apr 21, 2003 Abandoned
Array ( [id] => 7463683 [patent_doc_number] => 20040053289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Short interfering nucleic acid hybrids and methods thereof' [patent_app_type] => new [patent_app_number] => 10/410220 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7824 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053289.pdf [firstpage_image] =>[orig_patent_app_number] => 10410220 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/410220
Short interfering nucleic acid hybrids and methods thereof Apr 7, 2003 Abandoned
Array ( [id] => 6678462 [patent_doc_number] => 20030228603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Compositions selective for caffeine or aspartame and methods of using same' [patent_app_type] => new [patent_app_number] => 10/406903 [patent_app_country] => US [patent_app_date] => 2003-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 45168 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228603.pdf [firstpage_image] =>[orig_patent_app_number] => 10406903 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/406903
Compositions selective for caffeine or aspartame and methods of using same Apr 2, 2003 Abandoned
Array ( [id] => 7398978 [patent_doc_number] => 20040023265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Methods and compositions for nucleic acid ligands against Shiga toxin and/or Shiga-like toxin' [patent_app_type] => new [patent_app_number] => 10/386778 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13802 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023265.pdf [firstpage_image] =>[orig_patent_app_number] => 10386778 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/386778
Methods and compositions for nucleic acid ligands against Shiga toxin and/or Shiga-like toxin Mar 10, 2003 Abandoned
Array ( [id] => 7364441 [patent_doc_number] => 20040005593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Novel method for delivery and intracellular synthesis of siRNA molecules' [patent_app_type] => new [patent_app_number] => 10/383835 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7327 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005593.pdf [firstpage_image] =>[orig_patent_app_number] => 10383835 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/383835
Novel method for delivery and intracellular synthesis of siRNA molecules Mar 5, 2003 Abandoned
Array ( [id] => 7363879 [patent_doc_number] => 20040005546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Use of ribozymes in the detection of adventitious agents' [patent_app_type] => new [patent_app_number] => 10/375700 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7778 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005546.pdf [firstpage_image] =>[orig_patent_app_number] => 10375700 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/375700
Use of ribozymes in the detection of adventitious agents Feb 25, 2003 Abandoned
Array ( [id] => 7105093 [patent_doc_number] => 20050107316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent' [patent_app_type] => utility [patent_app_number] => 10/505482 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 27137 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107316.pdf [firstpage_image] =>[orig_patent_app_number] => 10505482 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/505482
Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent Feb 20, 2003 Abandoned
Array ( [id] => 7169504 [patent_doc_number] => 20050202428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Pluripotential stem cells' [patent_app_type] => utility [patent_app_number] => 10/504173 [patent_app_country] => US [patent_app_date] => 2003-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19166 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202428.pdf [firstpage_image] =>[orig_patent_app_number] => 10504173 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/504173
Pluripotential stem cells Feb 11, 2003 Abandoned
Array ( [id] => 7363473 [patent_doc_number] => 20040014956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Double-stranded oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/357529 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25633 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014956.pdf [firstpage_image] =>[orig_patent_app_number] => 10357529 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/357529
Double-stranded oligonucleotides Feb 2, 2003 Abandoned
Array ( [id] => 7287161 [patent_doc_number] => 20040147027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Complex for facilitating delivery of dsRNA into a cell and uses thereof' [patent_app_type] => new [patent_app_number] => 10/353902 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8738 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147027.pdf [firstpage_image] =>[orig_patent_app_number] => 10353902 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/353902
Complex for facilitating delivery of dsRNA into a cell and uses thereof Jan 27, 2003 Abandoned
Array ( [id] => 7393836 [patent_doc_number] => 20040038322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Potentiation of cancer therapies by ZNF217 inhibition' [patent_app_type] => new [patent_app_number] => 10/349627 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 40064 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038322.pdf [firstpage_image] =>[orig_patent_app_number] => 10349627 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/349627
Potentiation of cancer therapies by ZNF217 inhibition Jan 21, 2003 Abandoned
Array ( [id] => 6834727 [patent_doc_number] => 20030162273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Modulation of sulfate permease for photosynthetic hydrogen production' [patent_app_type] => new [patent_app_number] => 10/350298 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 20444 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162273.pdf [firstpage_image] =>[orig_patent_app_number] => 10350298 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/350298
Modulation of sulfate permease for photosynthetic hydrogen production Jan 21, 2003 Abandoned
Array ( [id] => 6856723 [patent_doc_number] => 20030130224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene' [patent_app_type] => new [patent_app_number] => 10/339934 [patent_app_country] => US [patent_app_date] => 2003-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13583 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130224.pdf [firstpage_image] =>[orig_patent_app_number] => 10339934 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/339934
Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene Jan 9, 2003 Abandoned
Array ( [id] => 6856723 [patent_doc_number] => 20030130224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene' [patent_app_type] => new [patent_app_number] => 10/339934 [patent_app_country] => US [patent_app_date] => 2003-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13583 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130224.pdf [firstpage_image] =>[orig_patent_app_number] => 10339934 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/339934
Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene Jan 9, 2003 Abandoned
Array ( [id] => 7322274 [patent_doc_number] => 20040136960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Devices and processes for distribution of genetic material to mammalian limb' [patent_app_type] => new [patent_app_number] => 10/339935 [patent_app_country] => US [patent_app_date] => 2003-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11716 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20040136960.pdf [firstpage_image] =>[orig_patent_app_number] => 10339935 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/339935
Devices and processes for distribution of genetic material to mammalian limb Jan 9, 2003 Abandoned
Array ( [id] => 7398672 [patent_doc_number] => 20040023239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Method of rna cleavage' [patent_app_type] => new [patent_app_number] => 10/296574 [patent_app_country] => US [patent_app_date] => 2003-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8516 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023239.pdf [firstpage_image] =>[orig_patent_app_number] => 10296574 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/296574
Method of rna cleavage Jan 6, 2003 Abandoned
Menu